Priority Research Centre for Health Behaviour, Faculty of Health, The University of Newcastle, Callaghan, Australia.
Patient Educ Couns. 2012 Jul;88(1):87-92. doi: 10.1016/j.pec.2011.12.014. Epub 2012 Jan 31.
This study aimed to examine preferred and perceived roles of haematological cancer survivors in treatment decision making.
Participants were within three years of diagnosis and registered with a cancer registry in one Australian state. 732 eligible survivors were invited to complete a paper and pencil survey.
268 survivors completed the survey (37% response rate). The majority of participants (46%) preferred a passive role in decision making. Thirty percent of participants preferred to make the decision in collaboration with the doctor, whereas 26% preferred an active role in decision making. Just over half of respondents (56%) reported an exact match between their preferred and perceived roles. Where discordance between preferred and perceived roles were identified, survivors were more likely to report having been more passively than actively involved compared to their preferred roles.
There is considerable variation in haematological cancer survivors' preferred and perceived roles in treatment decision making.
This study highlights the need to improve clinical communication to ensure that patient experiences align with their preferences for involvement in treatment decision making.
本研究旨在探讨血液癌幸存者在治疗决策中的偏好和感知角色。
参与者在诊断后三年内,并在澳大利亚一个州的癌症登记处注册。邀请了 732 名符合条件的幸存者完成一份纸质和铅笔调查。
268 名幸存者完成了调查(37%的回应率)。大多数参与者(46%)在决策中倾向于被动角色。30%的参与者希望与医生合作做出决策,而 26%的参与者希望在决策中发挥积极作用。超过一半的受访者(56%)报告说,他们的偏好和感知角色之间存在完全匹配。在偏好和感知角色之间存在不一致的情况下,幸存者更有可能报告与他们的偏好角色相比,他们更被动地参与而不是积极参与。
血液癌幸存者在治疗决策中偏好和感知角色存在很大差异。
本研究强调需要改善临床沟通,以确保患者的体验与他们在治疗决策中的参与偏好一致。